Utah Medical Products Stock Statistic Functions Linear Regression Angle
| UTMD Stock | USD 63.78 -0.26 -0.41% |
| Symbol |
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Linear Regression Angle indicator plots the angel of the trend line for each Utah Medical Products data point.
Utah Medical Technical Analysis Modules
Most technical analysis of Utah Medical help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Utah from various momentum indicators to cycle indicators. When you analyze Utah charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Utah Medical Products Inc
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company was incorporated in 1978 and is headquartered in Midvale, Utah. Utah Medical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 178 people. Market structure and macro sensitivity help explain how Utah Medical behaves across regimes. Defensive traits reduce macro sensitivity. Utah Medical has market cap of 204.33 M, P/E of 31.38, ROE of 9.54%.
Methodology
Unless otherwise specified, financial data for Utah Medical Products is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Utah (USA Stocks:UTMD) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We reference public filings and market reference sources and regulatory disclosures, including those published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data may be normalized and delayed in some cases. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Utah Medical Products may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Learn to be your own money manager
Tracking Utah Medical inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.
Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
Utah Medical Products pair trading
Pair trading with Utah Medical can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
Utah Medical Pair Trading
Utah Medical Products Pair Trading Analysis
Correlation matrices help investors optimize their Utah Medical tax-loss harvesting strategy by identifying the best available substitutes. The higher the correlation to Utah Medical Products, the less the portfolio's risk profile will shift during the wash-sale waiting period.
The pairwise correlation of Utah Medical measures the historical tendency for two assets to move in the same or opposite directions. High correlations between Utah Medical Products and another holding indicate concentrated risk that may amplify losses in adverse market conditions.
Use Correlation analysis and pair trading evaluation for Utah Medical to review hedging context. The method can be applied across sectors and broader equity sets.More Resources for Utah Stock Analysis
A comprehensive view of Utah Medical Products starts with financial statements and ratio context. Ratio context helps frame profitability, efficiency, and growth trends for Utah Medical Products Stock. Selected reports below provide context for Utah Stock:Utah Medical has market cap of 204.33 M, P/E of 31.38, operating margin of 31.11%. Review World Market Map for broader portfolio context. This reflects a position in Utah Medical Products within the allocation view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. Analysis related to Utah Medical should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Quarterly Earnings Growth -0.06 | Dividend Share 1.225 | Earnings Share 3.48 | Revenue Per Share | Quarterly Revenue Growth -0.01 |
Utah Medical Products market price can diverge from book value, the accounting figure shown on Utah balance sheet. Utah Medical's market capitalization is 204.33 M. A P/B ratio of 1.72 indicates the market values Utah Medical above its accounting book value. Enterprise value stands at 119.15 M. Intrinsic value is an estimate of underlying worth, separate from trading price and book value. The valuation process compares these measures for perspective.
It is useful to distinguish Utah Medical's value from its trading price, which are computed with different methods. For Utah Medical, key inputs include a P/E ratio of 31.38, a P/B ratio of 1.72, a profit margin of 29.3%, ROE of 9.54%. The quoted price is simply the exchange level where supply meets demand.